BIOCARTIS

In News

Press Release Biocartis NV: Biocartis Announces Agreement - GlobeNewswire

GlobeNewswire - Jun 09, 2026

Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test - Clinical Lab Products

Clinical Lab Products - Apr 17, 2026

Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures - Yahoo Finance

Yahoo Finance - Jan 12, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic - Pharmafile

Pharmafile - Jan 14, 2026

FDA greenlights diagnostic from Biocartis, BMS to find immunotherapy eligible patients - FirstWord PHARMA

FirstWord PHARMA - Sep 15, 2025

Press Release Biocartis NV: Biocartis to Collaborate with - GlobeNewswire

GlobeNewswire - Mar 24, 2026

FDA approves Biocartis Idylla Cdx MSI colorectal cancer test - BioWorld News

BioWorld News - Sep 16, 2025

Biocartis and Mayo Clinic to Collaborate on Rapid Breast Cancer Diagnostic Test - Femtech Insider

Femtech Insider - Jan 13, 2026

Idylla CDx MSI Test Earns FDA Approval in MSI-H Colorectal Cancer - CancerNetwork

CancerNetwork - Sep 16, 2025

FDA Grants Premarket Approval to Idylla CDx MSI Test for MSI-H CRC - OncLive

OncLive - Sep 15, 2025

Biocartis Introduces Influenza-Respiratory Virus Panel on Idylla Platform - respiratory-therapy.com

respiratory-therapy.com - Nov 09, 2023

DC Advisory advises Biocartis on enforcement by secured creditors and recapitalization of its main operating subsidiaries - DC Advisory

DC Advisory - Nov 16, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment